Evidence map›Paper›PMID 33154948›Full record

ArticleFrontiers in oncology2020

The Role of Tumor Deposits in Predicting the Efficacy of Chemotherapy in Stage III Colon Cancer.

Mingyu Shi, Hongzhi Zhang, Guozhong Yao, Jianjun Wu, Chuming Zhu, Xu Zhang, Yuan Ren

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mingyu ShiDepartment of General Surgery, Liyang People's Hospital, Liyang Branch of Jiangsu Provincial People's Hospital, Liyang, China.
Hongzhi ZhangDepartment of General Surgery, Liyang People's Hospital, Liyang Branch of Jiangsu Provincial People's Hospital, Liyang, China.
Guozhong YaoDepartment of General Surgery, Liyang People's Hospital, Liyang Branch of Jiangsu Provincial People's Hospital, Liyang, China.
Jianjun WuDepartment of General Surgery, Liyang People's Hospital, Liyang Branch of Jiangsu Provincial People's Hospital, Liyang, China.
Chuming ZhuDepartment of General Surgery, Liyang People's Hospital, Liyang Branch of Jiangsu Provincial People's Hospital, Liyang, China.
Xu ZhangDepartment of General Surgery, Liyang People's Hospital, Liyang Branch of Jiangsu Provincial People's Hospital, Liyang, China.
Yuan RenDepartment of General Surgery, Liyang People's Hospital, Liyang Branch of Jiangsu Provincial People's Hospital, Liyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the role of tumor deposits (TDs) in predicting the efficacy of chemotherapy in stage III colon cancer.

methodsUsing the SEER

resultsWe have identified 29,017 patients diagnosed with stage III colon cancer from the SEER database. The results of multivariate analyses showed that patients with the receipt of chemotherapy had 54.7% decreased risk of cancer-specific mortality compared with those not (HR = 0.453, 95% CI = 0.425-0.483,

conclusionsOur study demonstrated that the presence of TDs was associated with a dismal prognosis and high number of TDs would also contribute to the worse survival of colon cancer. High number of TDs did not affect the survival benefit of chemotherapy in stage III colon cancer.

Indexed as

chemotherapycolon cancerstage IIIsurvivaltumor deposits

Identifiers

PMID33154948
PMCPMC7591764
OpenAlexW3093125010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.